Enhanced cardiovascular risk in rheumatoid arthritis: elucidation, assessment, and management

Affiliations

¹ Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa.
² Preventive Cardio-Rheuma Clinic, Department of Rheumatology, Diakonhjemmet Hospital, 0370 Oslo, Norway.
³ Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa ; Department of Rheumatology, Hospital Universitario Marques de Valdecilla, IDIVAL, 39008 Santander, Spain.
⁴ Department of Rheumatology, Radboud University Nijmegen Medical Centre, 6525 Nijmegen, Netherlands.

Editorial

Patrick H Dessein et al. Biomed Res Int. 2015.

. 2015:2015:850671.

doi: 10.1155/2015/850671. Epub 2015 Mar 12.

¹ Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa.
² Preventive Cardio-Rheuma Clinic, Department of Rheumatology, Diakonhjemmet Hospital, 0370 Oslo, Norway.
³ Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa ; Department of Rheumatology, Hospital Universitario Marques de Valdecilla, IDIVAL, 39008 Santander, Spain.
⁴ Department of Rheumatology, Radboud University Nijmegen Medical Centre, 6525 Nijmegen, Netherlands.

No abstract available

References

1. Gonzalez-Gay M. A., Gonzalez-Juanatey C., Martin J. Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Seminars in Arthritis and Rheumatism. 2005;35(1):8–17. doi: 10.1016/j.semarthrit.2005.03.004. - DOI - PubMed
1. Dessein P. H., Norton G. R., Woodiwiss A. J., Joffe B. I., Wolfe F. Influence of nonclassical cardiovascular-risk factors on the accuracy of predicting subclinical atherosclerosis in rheumatoid arthritis. Journal of Rheumatology. 2007;34(5):943–951. - PubMed
1. Gonzalez-Gay M. A., Gonzalez-Juanatey C., Lopez-Diaz M. J., et al. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Care & Research. 2007;57(1):125–132. doi: 10.1002/art.22482. - DOI - PubMed
1. Rodríguez-Rodríguez L., López-Mejías R., García-Bermúdez M., González-Juanatey C., González-Gay M. A., Martín J. Genetic markers of cardiovascular disease in rheumatoid arthritis. Mediators of Inflammation. 2012;2012:14. doi: 10.1155/2012/574817.574817 - DOI - PMC - PubMed
1. Dessein P. H., Semb A. G. Could cardiovascular disease risk stratification and management in rheumatoid arthritis be enhanced? Annals of the Rheumatic Diseases. 2013;72(11):1743–1746. doi: 10.1136/annrheumdis-2013-203911. - DOI - PubMed